BeOne Medicines’ TEVIMBRA Receives FDA Priority Review for First-Line HER2+ GEA Treatment
BeOne Medicines Gains FDA Priority Review for TEVIMBRA in First-Line HER2+ Gastroesophageal Adenocarcinoma BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, has announced a major regulatory milestone in the development of a promising new treatment approach for patients with advanced…
Humana Q1 2026 Results; Full-Year Guidance Confirmed
Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance Humana has reported a solid set of financial results for the first quarter of 2026, highlighting steady operational performance, continued membership growth, and ongoing execution of…
Frontier Scientific Solutions Names Michelle D’Angelo as Chief Commercial Officer
Frontier Scientific Solutions Appoints Michelle D’Angelo as Chief Commercial Officer to Drive Strategic Growth Frontier Scientific Solutions, a recognized leader in cGMP-compliant, temperature-controlled logistics, has announced the appointment of Michelle D’Angelo as its new Chief Commercial Officer (CCO). This strategic…
MarinHealth Launches Women’s Lifelong Health Clinic
MarinHealth Introduces Comprehensive Women’s Lifelong Health and Wellness Clinic to Address Midlife and Beyond MarinHealth has announced the launch of its Women’s Lifelong Health and Wellness Clinic, a forward-thinking initiative designed to meet the evolving healthcare needs of women, particularly…
Strand Therapeutics to Present Preclinical Data on In Vivo CAR-T mRNA Platform at ASGCT 2026
Strand Therapeutics Advances In Vivo CAR-T Therapy with Programmable circRNA Platform Strand Therapeutics, a clinical-stage biotechnology company at the forefront of programmable RNA medicines, has announced the presentation of compelling preclinical data from its in vivo CAR-T program at the…
PACS Group Appoints Carey P. Hendrickson as CFO
PACS Group Appoints Carey P. Hendrickson as Chief Financial Officer, Marking New Phase of Financial Leadership PACS Group, a leading and rapidly expanding post-acute healthcare platform in the United States, has announced the appointment of Carey P. Hendrickson as its…
HCA Healthcare Appoints Cynthia Cifuentes-Finkel as SVP of Marketing and Corporate Affairs
HCA Healthcare Appoints Cynthia Cifuentes-Finkel as Marketing & Corporate Affairs SVP HCA Healthcare has announced the appointment of Cynthia Cifuentes-Finkel as its new Senior Vice President of Marketing and Corporate Affairs, with her tenure set to begin on June 8,…
Revolution EHR Introduces AI Scribe for Hands-Free Optometry Documentation
RevolutionEHR Unveils AI Scribe to Transform Documentation in Optometry Practices RevolutionEHR, a leading optometry-focused operating platform, has announced the launch of its latest innovation, AI Scribe—an intelligent, voice-enabled documentation assistant designed to significantly reduce administrative workload for optometrists. This new…
Motif Neurotech Wins FDA Clearance for First BCI Trial in Depression
Motif Neurotech Secures FDA Approval for First Clinical Trial of Depression-Focused BCI Motif Neurotech, a pioneering brain-computer interface company focused on mental health innovation, has reached a major milestone with regulatory clearance from the U.S. Food and Drug Administration to…
Seaport Therapeutics Appoints Dr. Sharon Mates to Board
Seaport Therapeutics Appoints Intra-Cellular Therapies Founder Dr. Sharon Mates to Board Seaport Therapeutics has strengthened its leadership team with the appointment of Dr. Sharon Mates to its Board of Directors, marking a significant step forward for the Boston-based clinical-stage company…
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status
vVARDIS Secures Apollo Investment, Reaches Unicorn Valuation vVARDIS Holding AG, an emerging leader in dental medtech innovation, has announced a strategic minority investment from funds managed by Apollo. This development marks a significant milestone for the company as it accelerates…
Genentech, Damon Wayans & diaTribe Launch DME Vision Loss Campaign
Genentech Teams Up With Damon Wayans and diaTribe for ‘All Eyes on DME’ Campaign on Diabetes Vision Loss Genentech, a member of the Roche Group, has launched a new awareness initiative titled “All Eyes on DME,” a campaign designed to…